255 related articles for article (PubMed ID: 16797926)
21. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation.
Peritt D
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):7-12. PubMed ID: 16399596
[TBL] [Abstract][Full Text] [Related]
22. In vitro experiments demonstrate that monocytes and dendritic cells are rendered apoptotic by extracorporeal photochemotherapy, but exhibit unaffected surviving and maturing capacity after 30 Gy gamma irradiation.
Rao V; Saunes M; Jørstad S; Moen T
Scand J Immunol; 2008 Dec; 68(6):645-51. PubMed ID: 19055700
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
24. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
25. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
Bladon J; Taylor PC
Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
[TBL] [Abstract][Full Text] [Related]
27. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
Rao V; Saunes M; Jørstad S; Moen T
Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease.
Merlin E; Goncalves-Mendes N; Hannani D; de la Torre A; Farges MC; Laroye H; Demeocq F; Kanold J; Vasson MP
Transpl Immunol; 2011 Jan; 24(2):100-6. PubMed ID: 21040785
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
32. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis.
Bladon J; Taylor PC
Dermatology; 2002; 204(2):104-7. PubMed ID: 11937734
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
35. [Extracorporeal photochemotherapy].
Viguier M; Pouthier F; Tiberghien P; Aubin F
Transfus Clin Biol; 2010 Feb; 17(1):28-33. PubMed ID: 20042357
[TBL] [Abstract][Full Text] [Related]
36. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
Marshall SR
Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
[TBL] [Abstract][Full Text] [Related]
37. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.
Gasová Z; Spísek R; Dolezalová L; Marinov I; Vítek A
Transfus Apher Sci; 2007 Apr; 36(2):149-58. PubMed ID: 17376742
[TBL] [Abstract][Full Text] [Related]
39. Photopheresis with UV-A light and 8-methoxypsoralen leads to cell death and to release of blebs with anti-inflammatory phenotype in activated and non-activated lymphocytes.
Stadler K; Frey B; Munoz LE; Finzel S; Rech J; Fietkau R; Herrmann M; Hueber A; Gaipl US
Biochem Biophys Res Commun; 2009 Aug; 386(1):71-6. PubMed ID: 19501044
[TBL] [Abstract][Full Text] [Related]
40. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
